Antidepressants and suicidal behaviour in unipolar depression

Acta Psychiatrica Scandinavica

Volumn 110, Issue 6, 2004, Pages 452-458

  Yerevanian, Boghos I ^a,b,d   Koek, R J ^a,b   Feusner, J D ^a,b   Hwang, S ^b,c   Mintz, J ^b,c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Antidepressants; Antidepressive agents, tricyclic; Depressive disorder; Dysthymic disorder; Serotonin reuptake inhibitors; Suicide; Suicide, attempted

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; DRUG WITHDRAWAL; DYSTHYMIA; FEMALE; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RISK; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DRUG MONITORING; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME; SUICIDE, ATTEMPTED; UNITED STATES;

EID: 9444258089     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2004.00437.x     Document Type: Article

References (33)

1. HEALY D, WHITAKER C. Antidepressants and suicide: risk-benefit conundrums. J Psychiatry Neurosci 2003;28:331-337.
2. GUZE SB, ROBINS E. Suicide and primary affective disorders. Br J Psychiatry 1970;117:437-448.
3. HARRIS EC, BARRACLOUGH B. Suicide as an outcome for mental disorders. Br J Psychiatry 1997;170:205-208.
4. ISACSSON G. Suicide prevention - a medical breakthrough? Acta Psychiatr Scand 2001;103:238-239.
5. CARLSTEN A, WAERN M, EKEDAHL A, RANSTAM J. Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf 2001;10:525-530.
6. HALL WD, MANT A, MITCHELL PB, RENDLE VA, HICKIE IB, MCMANUS P. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ 2003;326:1008-1012.
7. RIHMER Z, APPLEBY L, RIHMER A, BELSO N. Decreasing suicide in Hungary. Br J Psychiatry 2000;177:84.
8. OHBERG A, VUORI E, KLAUKKA T, LONNQVIST J. Antidepressants and suicide mortality. J Affect Disord 1998;50:225-233.
9. BARBUI C, CAMPOMORI A, D'AVANZO B, NEGRI E, GARATTINI S. Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol 1999;34:152-156.
10. LEVI F, LA VECCHIA C, LUCCHINI F et al. Trends in mortality from suicide, 1965-99. Acta Psychiatr Scand 2003;108:341-349.
11. ANDERSEN UA, ANDERSEN M, ROSHOLM JU, GRAM LF. Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disorders. Acta Psychiatr Scand 2001;104:458-465.
12. SUOMINEN K, ISOMETSA ET, HENDRIKSSON MM, OSTAMO AI, LONNQVIST JK. Inadequate treatment for major depression both before and after attempted suicide. Am J Psychiatry 1998;155:1778-1780.
13. ISACSSON G, BERGMAN U, RICH CL. Antidepressants, depression and suicide: an analysis of the San Diego study. J Affect Disord 1994;3:277-286.
14. ISACSSON G, HOLMGREN P, DRUID H, BERGMAN U. The utilization of antidepressants - a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994. Acta Psychiatr Scand 1997;96:94-100.
15. HENRIKSSON S, BOETHIUS G, ISACSSON G. Suicides are seldom prescribed antidepressants: findings from a prospective prescription database in Jamtland county, Sweden, 1985-95. Acta Psychiatr Scand 2001;103:301-306.
16. MARZUK PM, TARDIFF K, LEON AC et al. Use of prescription psychotropic drugs among suicide victims in New York City. Am J Psychiatry 1995;152:1520-1522.
17. ISACSSON G. Psychotropic drugs in the prevention of suicide. In: Program and Abstracts of the 16th European College of Neuropsychopharmacology Congress, September 20-24, 2003, Prague, Czech Republic. Symposium S0.25.01 (Available at: http://www.medscape.com/viewarticle/463050).
18. ISACSSON G, BERGMAN U, RICH CL. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 1996;41:1-8.
19. MONTGOMERY D, ROBERTS A, GREEN M, BULLOCK T, BALDWIN D, MONTGOMERY SA. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci 1994;244:211-215.
20. MÖLLER H, STEINMEYER EM. Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. Eur Neuropsychopharmacol 1994;4:55-59.
21. SZANTO K, MULSANT BH, HOUCK P, DEW MA, REYNOLDS CF, III. Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry 2003;60:610-617.
22. KHAN A, KHAN S, KOLTS R, BROWN W. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry 2003;160:790-792.
23. TOLLEFSON G, FAWCETT J, WINOKUR G et al. Evaluation of suicidality during pharmacologic treatment of mood and non-mood disorders. Ann Clin Psychiatry 1993;5:209-224.
24. MONTGOMERY SA. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995;5:5-13.
25. MÖLLER HJ. Suicide, suicidality and suicide prevention in affective disorders. Acta Psychiatr Scand 2003;108(suppl. 418):73-80.
26. ZIMMERMAN M, MATTIA J, POSTERNAK M. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159:469-473.
27. PARTONEN T, SIHVO S, LONNQVIST J. Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry 1996;57:572-575.
28. LEON A, KELLER M, WARSHAW M et al. Prospective study of fluoxetine treatment and suicidal behaviour in affectively ill subjects. Am J Psychiatry 1999;156:195-201.
29. YEREVANIAN BI, KOEK RJ, MINTZ J. Lithium, anticonvulsants and suicidal behaviour in bipolar disorder. J Affect Disord 2003;73:223-228.
30. BALDESSARINI RJ, TONDO L, HENNEN J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry 2003;64(suppl. 5):44-52.
31. DONOVAN S, CLAYTON A, BEEHARRY M et al. Deliberate self-harm and antidepressant drugs. Investigation of a possible link. Br J Psychiatry 2000;177:551-556.
32. MONTGOMERY S, MONTGOMERY D, GREEN M, BULLOCK T, BALDWIN D. Pharmacotherapy in the prevention of suicidal behaviour. J Clin Psychopharmacol 1992;12(suppl. 2):27S-31S.
33. MÖLLER H. Antidepressants - do they decrease or increase suicidality? Pharmacopsychiatry 1992;25:249-253.